Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 358 (21), 2231-9

Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis

Clinical Trial

Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis

James W B Bainbridge et al. N Engl J Med.


Early-onset, severe retinal dystrophy caused by mutations in the gene encoding retinal pigment epithelium-specific 65-kD protein (RPE65) is associated with poor vision at birth and complete loss of vision in early adulthood. We administered to three young adult patients subretinal injections of recombinant adeno-associated virus vector 2/2 expressing RPE65 complementary DNA (cDNA) under the control of a human RPE65 promoter. There were no serious adverse events. There was no clinically significant change in visual acuity or in peripheral visual fields on Goldmann perimetry in any of the three patients. We detected no change in retinal responses on electroretinography. One patient had significant improvement in visual function on microperimetry and on dark-adapted perimetry. This patient also showed improvement in a subjective test of visual mobility. These findings provide support for further clinical studies of this experimental approach in other patients with mutant RPE65. ( number, NCT00643747 [].).

Comment in

Similar articles

See all similar articles

Cited by 746 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Associated data